MR编号 | DE/H/0220/001 |
---|
药品名称 | IPV Mérieux and other NAPs |
---|
活性成分 | - inactivated type 1 polio virus 40.0 D antigen unit
- inactivated type 2 polio virus 8.0 D antigen
- inactivated type 3 polio virus 32.0 D antigen
|
---|
剂型 | Suspension for injection |
---|
上市许可持有人 | Sanofi Pasteur MSD GmbH
Paul Ehrlich Strasse 1
69181 Leimen
Germany |
---|
参考成员国 - 产品名称 | Germany (DE) IPV Merieux |
---|
互认成员国 - 产品名称 | - EMA (EM)
- Denmark (DK)
- Belgium (BE)
- Luxembourg (LU)
- Iceland (IS)
- Austria (AT)
- France (FR)
- Portugal (PT)
- Italy (IT)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
- Poland (PL)
- Lithuania (LT)
- Estonia (EE)
- Hungary (HU)
- Czechia (CZ)
- Romania (RO)
- Malta (MT)
- Croatia (HR)
- Spain (ES)
|
---|
许可日期 | 2004/02/18 |
---|
最近更新日期 | 2024/10/10 |
---|
药物ATC编码 | - J07BF03 poliomyelitis, trivalent, inactivated, whole virus
|
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Full Dossier Article 4.8 Di 65/65
- TypeLevel4:Biological: Vaccine
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|